Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2000 1
2003 3
2004 3
2005 13
2006 7
2007 12
2008 10
2009 11
2010 11
2011 14
2012 13
2013 13
2014 8
2015 19
2016 19
2017 17
2018 18
2019 15
2020 20
2021 27
2022 22
2023 26
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

282 results

Results by year

Filters applied: . Clear all
Page 1
T Cells in Pathogenic Infections.
Peng HY, Song J. Peng HY, et al. Pathogens. 2023 Apr 10;12(4):578. doi: 10.3390/pathogens12040578. Pathogens. 2023. PMID: 37111464 Free PMC article.
Autophagy in T-cell differentiation, survival and memory.
Wang L, Das JK, Kumar A, Peng HY, Ren Y, Xiong X, Yang JM, Song J. Wang L, et al. Among authors: peng hy. Immunol Cell Biol. 2021 Apr;99(4):351-360. doi: 10.1111/imcb.12422. Epub 2020 Nov 24. Immunol Cell Biol. 2021. PMID: 33141986 Review.
T Cell Response to SARS-CoV-2 Coinfection and Comorbidities.
Wang L, Peng HY, Pham A, Villazana E, Ballard DJ, Das JK, Kumar A, Xiong X, Song J. Wang L, et al. Among authors: peng hy. Pathogens. 2023 Feb 15;12(2):321. doi: 10.3390/pathogens12020321. Pathogens. 2023. PMID: 36839596 Free PMC article. Review.
Methylone produces antidepressant-relevant actions and prosocial effects.
Li Z, Peng HY, Lee CS, Lin TB, Hsieh MC, Lai CY, Wu HF, Chen LC, Chen MC, Chou D. Li Z, et al. Among authors: peng hy. Neuropharmacology. 2024 Jan 1;242:109787. doi: 10.1016/j.neuropharm.2023.109787. Epub 2023 Oct 31. Neuropharmacology. 2024. PMID: 37913982
Long-acting HIV fusion inhibitor albuvirtide combined with ritonavir-boosted lopinavir for HIV-1-infected patients after failing the first-line antiretroviral therapy: 48-week randomized, controlled, phase 3 non-inferiority TALENT study.
Su B, Yao C, Zhao QX, Cai WP, Wang M, Lu HZ, Mu TT, Chen YY, Liu L, Wang H, He Y, Zheng YH, Li LH, Chen JF, Yu JH, Zhu B, Zhao M, Sun YT, Lun WH, Zhang YH, Wang H, Xia W, Sun LJ, Dai LL, Jiang TY, Wang MX, Zheng QS, Peng HY, Wang Y, Hu M, Liu X, Lu RJ, Hu JH, Sun CC, Xing H, Shao YM, Xie D, Zhang T, Zhang FJ, Wu H. Su B, et al. Among authors: peng hy. J Infect. 2022 Sep;85(3):334-363. doi: 10.1016/j.jinf.2022.05.034. Epub 2022 Jun 1. J Infect. 2022. PMID: 35659547 No abstract available.
282 results